143 related articles for article (PubMed ID: 5022797)
1. [Mechanisms of action of drug therapy of cancer].
García G
Gac Med Mex; 1972 Feb; 103(2):129-45. PubMed ID: 5022797
[No Abstract] [Full Text] [Related]
2. [Current aspects of drug therapy of cancer].
Vicente J
Rev Clin Esp; 1970 Dec; 119(6):501-16. PubMed ID: 4928318
[No Abstract] [Full Text] [Related]
3. [Modern methods of therapeutic management of malignant proliferative disorders].
Sroczyński J
Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
[No Abstract] [Full Text] [Related]
4. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
Sartorelli AC; Booth BA
Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
[No Abstract] [Full Text] [Related]
5. Current concepts in the drug treatment of cancer.
Schein PS
Med Times; 1978 Mar; 106(3):26-9. PubMed ID: 634095
[No Abstract] [Full Text] [Related]
6. Are targeted therapies really targeted?
Schilsky RL
Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
[No Abstract] [Full Text] [Related]
7. [Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance].
Pourquier P; Pommier Y
Bull Cancer; 1998 Dec; Spec No():5-10. PubMed ID: 9932078
[TBL] [Abstract][Full Text] [Related]
8. [Cellular biology and antitumoral chemotherapy].
Lanza I
Minerva Pediatr; 1968 Jun; 20(24):1233-9. PubMed ID: 5736916
[No Abstract] [Full Text] [Related]
9. Cancer chemotherapeutic agents.
Krakoff IH
CA Cancer J Clin; 1977; 27(3):130-43. PubMed ID: 406014
[No Abstract] [Full Text] [Related]
10. The potential of statins as part of anti-cancer treatment.
Sleijfer S; van der Gaast A; Planting AS; Stoter G; Verweij J
Eur J Cancer; 2005 Mar; 41(4):516-22. PubMed ID: 15737555
[TBL] [Abstract][Full Text] [Related]
11. [Problems and possibilities of experimental cancer research].
Sachsenmaier W
Osterr Z Erforsch Bekampf Krebskr; 1972; 27(3):149-58. PubMed ID: 5068525
[No Abstract] [Full Text] [Related]
12. [Problem of immunologic stimulation of unspecific rejection mechanisms of the neoplastic-patients in the cancer-multiple therapy concept von Ardenne].
Lippmann HG
Dtsch Gesundheitsw; 1971 Jul; 26(27):1241-5. PubMed ID: 5093312
[No Abstract] [Full Text] [Related]
13. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
14. [Potentiation of the effects of antineoplastic agents].
Wad T; Oara H
Gan No Rinsho; 1971 Mar; 17(3):173-7. PubMed ID: 4926146
[No Abstract] [Full Text] [Related]
15. [Effect of various chemotherapeutic agents on DNA synthesis in the cells of human strains of breast and laryngeal cancer, chorionepithelioma and Wilms' tumor].
Revazova ES
Biull Eksp Biol Med; 1981 Oct; 91(10):469-71. PubMed ID: 6274446
[No Abstract] [Full Text] [Related]
16. [Chemotherapy using cyclic phosphamide esters].
Gerhartz H
Med Monatsschr; 1973 Sep; 27(9):395-7. PubMed ID: 4588488
[No Abstract] [Full Text] [Related]
17. [Inhibitory action of retinoic acid and N-(4-carboxyphenyl)-retinamide on the biosynthesis of DNA, RNA and protein in Ehrlich ascites carcinoma].
Song ZP; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):418-20. PubMed ID: 6242543
[No Abstract] [Full Text] [Related]
18. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
19. [Drug therapy of cancer].
Brux Med; 1974 Oct; 54(10):583-92. PubMed ID: 4434239
[No Abstract] [Full Text] [Related]
20. [Indication for neoplasm chemotherapy and administration of antineoplastic agents].
Hiraki K; Kimura I
Naika; 1970 Jun; 25(6):1163-9. PubMed ID: 5431259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
